The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry

2009/06/17 by Andrew N. Hoofnagle, Mark H. Wener · 27 citations
Chemistry · Engineering · Medicine · #Advanced Proteomics Techniques and Applications #Analyte #Antibody #Biochemical engineering #Biology #Biosensors and Analytical Detection #Chemistry #Chromatography #Computational biology #Computer science #Engineering #Immunoassay #Immunology #Mass Spectrometry Techniques and Applications #Mass spectrometry #Medicine #Tandem mass spectrometry

paper · doi:10.1016/j.jim.2009.06.003

openalex publication_date 2009/06/17 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05

Cited by

• Designing diagnostic platforms for analysis of disease patterns and probing disease emergence
• The Time Has Come for Quantitative Protein Mass Spectrometry Tests That Target Unmet Clinical Needs
• Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia. [europepmc]
• Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry. [europepmc]
• A targeted proteomics-based pipeline for verification of biomarkers in plasma. [europepmc]
• Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. [europepmc]
• Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MS. [europepmc]
• Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. [europepmc]
• Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum. [europepmc]
• Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. [europepmc]
• Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics. [europepmc]
• From lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometry. [europepmc]
• Bioanalytical chemistry of cytokines--a review. [europepmc]
• Measurement by a Novel LC-MS/MS Methodology Reveals Similar Serum Concentrations of Vitamin D-Binding Protein in Blacks and Whites. [europepmc]
• Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. [europepmc]
• Quality Issues of Research Antibodies. [europepmc]
• Personalized Proteomics: The Future of Precision Medicine. [europepmc]
• Single Molecule Nanopore Spectrometry for Peptide Detection. [europepmc]
• Revisiting biomarker discovery by plasma proteomics. [europepmc]
• Clinical potential of mass spectrometry-based proteogenomics. [europepmc]
• Deep learning-enabled point-of-care sensing using multiplexed paper-based sensors. [europepmc]
• Unraveling the Hook Effect: A Comprehensive Study of High Antigen Concentration Effects in Sandwich Lateral Flow Immunoassays. [europepmc]
• Review: Detection and quantification of proteins in human urine. [europepmc]
• Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets. [europepmc]
• Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach. [europepmc]
• Liquid chromatography-tandem mass spectrometry for clinical diagnostics. [europepmc]
• Exploring the Potential of Bioactive Peptides: From Natural Sources to Therapeutics. [europepmc]